Diabetes, Diabetes Mellitus, Type 2
Conditions
Brief summary
This observational study is conducted in Europe. The aim of this non-interventional (observational) study is to evaluate the efficacy of liraglutide (Victoza®) and to assess the conditions of use of Victoza® in daily medical practice in France.
Interventions
DRUGliraglutide
Prescription is done at the discretion of the prescribing physician as part of normal clinical routine.
Sponsors
Novo Nordisk A/S
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients diagnosed with type 2 diabetes * Patients having recently started (for less than one week) or starting liraglutide (Victoza®) treatment
Exclusion criteria
* Hypersensitivity (allergy) to liraglutide or to any of the excipients * Patient is participating in a clinical trial at the inclusion * Type 1 diabetes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of patients still in liraglutide treatment and having a HbA1c (glycosylated haemoglobin) value below 7.0% | Month 24 |
Secondary
| Measure | Time frame |
|---|---|
| Change in HbA1c at month 3 | Month 0, Month 3 |
| Change in HbA1c at month 6 | Month 0, Month 6 |
| Change in HbA1c at month 12 | Month 0, Month 12 |
| Change in HbA1c at month 18 | Month 0, Month 18 |
| Change in HbA1c at month 24 | Month 0, Month 24 |
| Change in fasting plasma glucose (FPG) at month 3 | Month 0, Month 3 |
| Change in fasting plasma glucose (FPG) at month 6 | Month 0, Month 6 |
| Change in fasting plasma glucose (FPG) at month 12 | Month 0, Month 12 |
| Change in fasting plasma glucose (FPG) at month 18 | Month 0, Month 18 |
| Change in fasting plasma glucose (FPG) at month 24 | Month 0, Month 24 |
| Change in Body Weight at Month 3 | Month 0, Month 3 |
| Change in Body Weight at Month 6 | Month 0, Month 6 |
| Change in Body Weight at Month 12 | Month 0, Month 12 |
| Change in Body Weight at Month 18 | Month 0, Month 18 |
| Change in Body Weight at Month 24 | Month 0, Month 24 |
Countries
France
Outcome results
None listed